CON# IDIQ-FDA-VIVO-TOX
    Sponsoring Agency HHS
    POP 6/29/15 - 9/17/20 (5 years)

Description

The U.S. Food and Drug Administration's (FDA), Center for Tobacco Products (CTP) has a need for in vivo toxicology of tobacco and related products. Activities under the proposed contract shall include, but are not limited to, assessing tobacco products in in vivo genetic toxicology nonclinical studies utilizing the inhalation route, which shall include pharmacokinetic analyses (PK) by varying routes, in addition to inhalation.

  • $1.5m Aggregate Dollars Obligated
  • $1.5m Aggregate Base & Exercised Options
  • $1.5m Aggregate Base & All Options (Ceiling)

Market Stats Related Contracts